abstract |
The present invention relates to a process for the preparation of compounds of formula (I) (see formula) in which Q1 is a group selected from: (see formulas) and a group * -NR6-Q2-A or, if it is appropriate, its salts and / or isomers, tautomers, solvates or pharmaceutically acceptable isotopic variations thereof, as well as intermediates used in said process. |